TransUnion announced strong Q4 2021 results, with revenue of $790 million, a 21% increase compared to Q4 2020. Net income attributable to TransUnion was $1,017 million, or $5.27 per diluted share, impacted by a $982 million gain on the disposal of the Healthcare business. Adjusted EBITDA was $282 million, up 14% from the prior year.
Delivered strong quarter driven by diversified growth initiatives.
Enhanced portfolio with new capabilities in high-growth markets.
Announced intent to acquire Verisk Financial Services.
Extinguished $640 million of debt related to the Sontiq acquisition during the fourth quarter.
TransUnion expects to deliver 11% - 12% organic revenue growth excluding U.S. mortgage impact in the first quarter and 9% - 11% for the full year 2022.
Visualization of income flow from segment revenue to net income